These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38669119)

  • 1. Gender-Affirming Hormone Therapy and Cervical Cancer Screening Rates in Transgender Men and Nonbinary People: A Cross-Sectional Study from a Boston Community Health Center.
    Fleming J; Grasso C; Mayer KH; Reisner SL; Potter J; Streed CG
    LGBT Health; 2024 Oct; 11(7):514-521. PubMed ID: 38669119
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of cervical cancer among Italian AFAB transgender people.
    Lami A; Alvisi S; Siconolfi A; Seracchioli R; Meriggiola MC
    Curr Probl Cancer; 2024 Jun; 50():101103. PubMed ID: 38744064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
    Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
    JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy.
    Sanna E; Lami A; Giacomelli G; Alvisi S; Paccapelo A; Seracchioli R; Meriggiola MC
    Front Endocrinol (Lausanne); 2024; 15():1416121. PubMed ID: 39391880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental Health Status of Cisgender and Gender-Diverse Secondary School Students in China.
    Wang Y; Yu H; Yang Y; Drescher J; Li R; Yin W; Yu R; Wang S; Deng W; Jia Q; Zucker KJ; Chen R
    JAMA Netw Open; 2020 Oct; 3(10):e2022796. PubMed ID: 33107922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.
    Reisner SL; Deutsch MB; Mayer KH; Pletta DR; Campbell J; Potter J; Keuroghlian AS; Hughto JMW; Asquith A; Pardee DJ; Harris A; Quint M; Grasso C; Gonzalez A; Radix A
    J Gen Intern Med; 2024 May; 39(7):1164-1172. PubMed ID: 37989820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE; DeChants JP; Price MN; Davis CK
    J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/Ethnic Differences in Sexually Transmitted Infection Testing Among Transgender Men and Nonbinary Assigned Female at Birth Young Adults in the United States: a National Study.
    Agénor M; Lett E; Ramanayake N; Zubizarreta D; Murchison GR; Eiduson R; Gordon AR
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):2900-2910. PubMed ID: 36469284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
    Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
    Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
    McDowell A; Rieu-Werden ML; Atlas SJ; Fields CD; Goldstein RH; Gundersen GD; Haas JS; Higashi RT; Pruitt SL; Silver MI; Tiro JA; Kamineni A
    LGBT Health; 2024 Oct; 11(7):563-569. PubMed ID: 38648535
    [No Abstract]   [Full Text] [Related]  

  • 16. Transgender patients and gender-affirming hormone therapy through the mid-life.
    Mehta JM; Kanell S; Borowicz CEA; Fisher MA
    Maturitas; 2024 Nov; 189():108093. PubMed ID: 39178607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy.
    Marinelli L; Bichiri A; Cagnina S; Castella L; Ghigo E; Motta G
    J Endocrinol Invest; 2024 Nov; 47(11):2843-2850. PubMed ID: 38644453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Berzansky I; Reynolds CA; Charlton BM
    Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey.
    Kidd JD; Goetz TG; Shea EA; Bockting WO
    Drug Alcohol Depend; 2021 Feb; 219():108474. PubMed ID: 33360852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States.
    Grindlay K; Obedin-Maliver J; Ragosta S; Hastings J; Lunn MR; Flentje A; Capriotti MR; Dastur Z; Lubensky ME; Moseson H
    Am J Obstet Gynecol; 2024 Jun; 230(6):657.e1-657.e17. PubMed ID: 38365096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.